Adams Street Partners LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Adams Street Partners LLC reported 6 stock positions worth $112.8 million. Its top holding was Rimini Street (RMNI) at 55.8% of the portfolio, followed by Corvus Pharmaceuticals (CRVS, 15.5%) and Mineralys Therapeutics (MLYS, 12.3%). Compared with Q3 2024, it opened 2 new positions, sold out of 2 and reduced 1. The biggest buy was a new position in Paymentus Class A (PAY) and the biggest sale an exit from Paylocity (PCTY).
- Most Recent 13F
- Q2 2026
- Location
- CHICAGO, IL
- CIK
- 0001193586
- Portfolio Value
- $112.8M (Q4 2024)
- SEC Filing
- 0001104659-25-013428 ↗ filed Feb 14, 2025
Holdings Value
Holdings 6 stocks · $112.8M
| RMNI Rimini Street Inc. | 55.77% | 23,565,433 | $62.9M | No change |
| CRVS Corvus Pharmaceuticals Inc. | 15.53% | 3,275,616 | $17.5M | No change |
| MLYS Mineralys Therapeutics Inc. | 12.33% | 1,129,807 | $13.9M | Reduce -26.3% |
| PAY Paymentus Holdings Inc. Class A | 7.94% | 274,039 | $9.0M | New |
| PVLA Palvella Therapeutics Inc. | 4.36% | 409,666 | $4.9M | New |
| VACASA INC | 4.07% | 938,221 | $4.6M | No change |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 4 | $442.7M | BLLN, RMNI, CBRS, CRVS |
| Q1 2026 | 3 | $260.3M | BLLN, RMNI, CRVS |
| Q4 2025 | 5 | $263.9M | BLLN, RMNI, CRVS, PAY, CAI |
| Q3 2025 | 5 | $153.2M | RMNI, CRVS, PGY, IOT, PAY |
| Q2 2025 | 6 | $142.0M | RMNI, IOT, CRVS, PAY, PVLA |
| Q1 2025 | 7 | $113.0M | RMNI, PVLA, CRVS, VACASA INC, PAY |
| Q4 2024 | 6 | $112.8M | RMNI, CRVS, MLYS, PAY, PVLA |
| Q3 2024 | 6 | $181.7M | PCTY, RMNI, QTWO, MLYS, CRVS |
| Q2 2024 | 9 | $242.7M | RMNI, PCTY, PDD, QTWO, MLYS |
| Q1 2024 | 12 | $251.7M | PCTY, RMNI, QTWO, MLYS, COIN |